Amikacin 1g/4mL Injection

Amikacin 1g/4mL is an injectable aminoglycoside antibiotic used for serious bacterial infections when the likely or confirmed organism is susceptible. It may be used for severe infections involving the urinary tract, lungs, bloodstream, bones, joints, abdomen, or other sites, depending on culture results and the prescriber's plan. Amikacin does not work for viral infections such as colds or flu, and unnecessary use increases antibiotic resistance risk. This medicine requires careful dosing because aminoglycosides can affect the kidneys, hearing, balance, nerves, and breathing muscles.
Amikacin 1g/4mL is given by a healthcare professional as an IV infusion or intramuscular injection. Use the full prescribed course even if symptoms improve. Hydration, kidney-function monitoring, and drug-level monitoring may be needed. Do not skip doses or use leftover antibiotics.
Amikacin binds to bacterial ribosomes and disrupts protein production, leading to bacterial cell death. It is active against selected gram-negative and other susceptible bacteria, but only when the organism is sensitive to amikacin.
Possible side effects include injection-site pain, nausea, vomiting, rash, fever, headache, or abnormal kidney tests. Serious risks include kidney injury, hearing loss, ringing in the ears, dizziness, balance problems, numbness, tingling, muscle weakness, breathing difficulty, severe allergy, or severe diarrhoea.
Use caution in kidney disease, dehydration, older age, hearing or balance disorders, neuromuscular disease, pregnancy, and concurrent nephrotoxic or ototoxic medicines such as vancomycin, amphotericin B, cisplatin, loop diuretics, or other aminoglycosides. Report tinnitus, hearing change, dizziness, reduced urine, or weakness immediately.
Provides potent injectable antibacterial action for serious susceptible infections, especially when culture results or clinical severity support aminoglycoside therapy.
Amikacin 1g/4mL is used for serious bacterial infections caused by organisms likely or proven to be susceptible to amikacin.
No. Amikacin does not treat colds, flu, or other viral infections.
Amikacin can affect kidney function, so dose and interval may need adjustment based on kidney tests.
Report ringing in the ears, hearing loss, dizziness, vertigo, or balance problems immediately.
Sometimes, but combinations need clinician review because some medicines increase kidney or hearing-related toxicity.
No. Complete the prescribed course unless the doctor changes therapy based on response or test results.
Amikacin, Aminoglycoside antibiotic, Serious bacterial infection medicine, Gram negative antibiotic, Kidney monitoring antibiotic, Ototoxicity warning, AR: Amikacin / حقن, FR: Amikacin /, PT: Amikacin / injeção, ES: Amikacin / inyección, RU: Amikacin / инъекция, ID: Amikacin / injeksi, VI: Amikacin / thuốc tiêm, MS: Amikacin / suntikan, TL: Amikacin / iniksyon, ZH-SG: Amikacin / 注射剂
International B2B Enquiry
Send a structured B2B enquiry for Amikacin 1g/4mL Injection under Antibiotic / Anti-infective. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Amikacin 1g/4mL Injection